“At present, in some patients, there is a gap between patient symptoms and true abnormalities which can be identified with routine testing techniques including X-ray and MRI. Halifax Biomedical technology is unique and may succeed in providing information towards bridging this gap. This research partnership between Halifax Biomedical and our team will work to identify patient benefit,” said Neil Manson, MD, principal investigator of the study.
Halifax Biomedical is an evidence-based orthopedic clinical measurements company.
More articles on devices:
After disappointing 2Q, Mazor CEO rallies troops: 11 things to know
Zacks maintains “neutral” rating for Zimmer post-Biomet acquisition
Blue Belt Technologies’ Navio system used for 500th partial knee replacement procedure
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
